○Yu Miyazaki (Department of RNA Biology and Neuroscience, Graduate School of Medicine, Osaka University, Japan)
Session information
Overcome the Challenges of Neurological Disorders
[OC-05] Gene & Cell Therapy for Neurological Diseases
Sat. May 26, 2018 8:00 AM - 10:00 AM Room 8 (Royton Sapporo / Empress Hall (2F))
Chair: Shin-ichi Muramatsu(Division of Neurology, Jichi Medical University, Japan), Hitoshi Okazawa(Medical Research Institute, Tokyo Medical and Dental University, Japan)
To introduce recent advances on gene & cell therapy for neurological diseases. The audience will understand the background and applications of key technologies such as adeno-associated viral vectors and iPS cells. These innovations bring teasible therapies for many intractable diseases.
○Nathalie Cartier1, Sandro Alves2, Wilhelm Christaller3, Enejda Subashi4, Radhia Kacher5, Antonin Lamazière2, Gaetan Despres6, Frederic Saudou3, Jocelyne Caboche5, Sandrine Betuing5 (1.INSERM UMR1169 Université Paris Saclay, France, 2.BrainVectis Therapeutics, France, 3.INSERM U1216 and University Grenoble Alpes, Grenoble Institut des Neurosciences, France, 4.INSERM UMR1169 Université Paris Saclay, France, 5.Institute of Biology Paris-Seine, Sorbonne Universités, France, 6.Laboratory of Mass Spectrometry, INSERM ERL 1157, Sorbonne Universités-)
○Kohji Itoh1,5, Daisuke Tsuji1, Kyo-ya Ohnishi1, Ryo-suke Watanabe2, Katsuhito Asai3,5, Shin-ichi Muramatsu4,5 (1.Department of Medicinal Biotechnology, Graduate School of Biomedical Sciences. Tokushima University, Japan, 2.Faculty of Pharmaceutical Sciences, Tokushima University, Japan, 3.Gene Therapy Research Institute, Co., Ltd., Japan, 4.Division of Neurology, Jichi Medical University, Japan, 5.TR-SPRINT, AMED, Japan)
○Jun Takahashi (Center for iPS Cell Research and Application, Japan)